Micrus Endovascular to Present at 2nd Annual Jefferies Healthcare Conference

SAN JOSE, Calif.--(Business Wire)--
Micrus Endovascular Corporation (NASDAQ:MEND) today announced that
Robert Stern, President and COO, will present at the Jefferies 2nd
Annual Healthcare Conference on Thursday, June 26 at 1:00 p.m. Eastern
time (10:00 a.m. Pacific time).

A live audio webcast of the conference presentation will be
available via the Internet by visiting the Investor Relations section
of Micrus' Web site at www.micruscorp.com. An archive of the
presentation will be available on the Web site for 14 days.

About Micrus Endovascular Corporation

Micrus develops, manufactures and markets implantable and
disposable medical devices for use in the treatment of cerebral
vascular diseases. Micrus products are used by interventional
neuroradiologists, interventional neurologists and neurosurgeons to
treat both cerebral aneurysms responsible for hemorrhagic stroke and
intracranial atherosclerosis, which may lead to ischemic stroke.
Hemorrhagic and ischemic stroke are both significant causes of death
and disability worldwide. The Micrus product line enables physicians
to gain access to the brain in a minimally invasive manner through the
vessels of the circulatory system. Micrus' proprietary,
three-dimensional microcoils automatically deploy within the aneurysm,
forming a scaffold that conforms to a wide diversity of aneurysm
shapes and sizes. Micrus also sells accessory devices and products
used in conjunction with its microcoils. For more information, visit
www.micruscorp.com.

Micrus Endovascular Corporation
Robert Stern
President and Chief Operating Officer
408-433-1400
ras@micruscorp.com
or
Investor Contacts:
Lippert/Heilshorn & Associates, Inc.
Bruce Voss or Jody Cain
310-691-7100
bvoss@lhai.com
jcain@lhai.com

Copyright Business Wire 2008